Achieving confidence in mechanism for drug discovery and development

Drug Discovery Today

Volumn 12, Issue 21-22, 2007, Pages 924-930

  Pitluk, Zach ^a   Khalil, Iya ^a  

^a Gene Network Sciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C;

BAYES THEOREM; BIOCHEMISTRY; CANCER THERAPY; CHEMICAL ENGINEERING; DNA SEQUENCE; DRUG INDUSTRY; DRUG MECHANISM; DRUG RESEARCH; GENE EXPRESSION; GENOME ANALYSIS; METABOLOMICS; MODEL; MOLECULAR DYNAMICS; MOLECULAR THERAPY; MONTE CARLO METHOD; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SIMULATION; TECHNOLOGY;

ANIMALS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; DRUG INDUSTRY; HUMANS; MODELS, BIOLOGICAL;

EID: 35748950099     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2007.10.001     Document Type: Review

References (42)

1. Dickens C., and McLenan J. A Tale of Two Cities (1859), T.B. Peterson and Brothers
2. Bilheimer D.W., Goldstein J.L., et al. Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J. Clin. Invest. 56 (1975) 1420-1430
3. Dawber T.R., Moore F.E., et al. Coronary heart disease in the Framingham study. Am. J. Public Health Nations Health 47 4 Part 2 (1957) 4-24
4. Stampfer M.J., Sacks F.M., et al. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 325 (1991) 373-381
5. Kola I., and Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat. Rev. Drug Discov. 3 (2004) 711-715
6. Mourant J.R., Yamada Y.R., et al. FTIR spectroscopy demonstrates biochemical differences in mammalian cell cultures at different growth stages. Biophys. J. 85 (2003) 1938-1947
7. Antonarakis S.E., Youssoufian H., et al. Molecular genetics of hemophilia A in man (factor VIII deficiency). Mol. Biol. Med. 4 (1987) 81-94
8. Barton N.W., Furbish F.S., et al. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1913-1916
9. Sawyers C.L. Chronic myeloid leukaemia. N. Engl. J. Med. 340 (1999) 1330-1340
10. Pulst S.M. Neurogenetics: single gene disorders. J. Neurol. Neurosurg. Psychiatry 74 (2003) 1608-1614
11. Varmus H. The new era in cancer research. Science 312 (2006) 1162-1165
12. Brem R.B., Yvert G., et al. Genetic dissection of transcriptional regulation in budding yeast. Science 296 (2002) 752-755
13. Schadt E.E., Monks S.A., et al. A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets. Biochem. Soc. Trans. 31 (2003) 437-443
14. Schadt E.E. Exploiting naturally occurring DNA variation and molecular profiling data to dissect disease and drug response traits. Curr. Opin. Biotechnol. 16 (2005) 647-654
15. Rockman M.V., and Kruglyak L. Genetics of global gene expression. Nat. Rev. Genet. 7 (2006) 862-872
16. Schadt E.E., Lamb J., et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat. Genet. 37 (2005) 710-717
17. Ahmad A.M. Recent advances in pharmacokinetic modeling. Biopharm. Drug Dispos. 28 (2007) 135-143
18. Ong S.E., and Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1 (2005) 252-262
19. Stoughton R.B., and Friend S.H. How molecular profiling could revolutionize drug discovery. Nat. Rev. Drug Discov. 4 (2005) 345-350
20. Fan J.B., Chee M.S., et al. Highly parallel genomic assays. Nat. Rev. Genet. 7 (2006) 632-644
21. Butcher E.C. Can cell systems biology rescue drug discovery?. Nat. Rev. Drug Discov. 4 (2005) 461-467
22. Aksenov S.V., Church B., et al. An integrated approach for inference and mechanistic modeling for advancing drug development. FEBS Lett. 579 (2005) 1878-1883
23. Friedman N. Inferring cellular networks using probabilistic graphical models. Science 303 (2004) 799-805
24. Basso K., Margolin A.A., et al. Reverse engineering of regulatory networks in human B cells. Nat. Genet. 37 (2005) 382-390
25. di Bernardo D., Thompson M.J., et al. Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat. Biotechnol. 23 (2005) 377-383
26. Pe'er D., Regev A., et al. Inferring subnetworks from perturbed expression profiles. Bioinformatics 17 Suppl 1 (2001) S215-S224
27. Smith V.A., Jarvis E.D., et al. Evaluating functional network inference using simulations of complex biological systems. Bioinformatics 18 (2002) 216S-224S
28. Imoto S., Higuchi T., et al. Combining microarrays and biological knowledge for estimating gene networks via Bayesian networks. Proc. IEEE Comput. Soc. Bioinform. Conf. 2 (2003) 104-113
29. Imoto S., Kim S., et al. Bayesian network and nonparametric heteroscedastic regression for nonlinear modeling of genetic network. J. Bioinform. Comput. Biol. 1 (2003) 231-252
30. Pearl J. Causality: Models, Reasoning, and Inference (2000), Cambridge University Press
31. Heckerman D. A tutorial on learning with Bayesian networks. In: Jordan M.I. (Ed). Learning in Graphical Models (1999), MIT Press, Cambridge, Massachusetts 301-354
32. Mackay D.J.C. Introduction to Monte Carlo methods. In: Jordan M.I. (Ed). Learning in Graphical Models (1999), MIT Press 175-204
33. Sachs K., Perez O., et al. Causal protein-signaling networks derived from multiparameter single-cell data. Science 308 (2005) 523-529
34. Bose R., Molina H., et al. Phosphoproteomic analysis of Her2/neu signaling and inhibition. PNAS 103 (2006) 9773-9778
35. Segal E., Friedman N., et al. From signatures to models: understanding cancer using microarrays. Nat. Genet. 37 Suppl (2005) S38-S45
36. Gevaert O., Smet F.D., et al. Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics 22 (2006) e184-e190
37. Clayton T.A., Lindon J.C., et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440 (2006) 1073-1077
38. Sheiner L.B. Learning versus confirming in clinical drug development. Clin. Pharmacol. Ther. 61 (1997) 275-291
39. Grabowski H., Vernon J., et al. Returns on research and development for 1990s new drug introductions. Pharmacoeconomics 20 Suppl 3 (2002) 11-29
40. PHRMA (2006-2007). Annual Report
41. O'Malley B.W. Molecular biology. Little molecules with big goals. Science 313 (2006) 1749-1750
42. Woolf P.J., Prudhomme W., et al. Bayesian analysis of signaling networks governing embryonic stem cell fate decisions. Bioinformatics 21 6 (2005) 741-753